RA-ILD has worse outcomes than RA and is most likely in those with extra-articular RA manifestations and in those who are ...
A new approach targets the B-cell pathway with bispecific antibodies, building on decades of research that establishes the ...
The study also presented the first external validation and use in patients with early RA of six proposed screening strategies ...
A biomarker panel for IPF may identify RA patients at higher risk for ILD, supporting biological overlap between IPF and ...
What are called autoimmune diseases can affect just about every part of the body – and tens of millions of people. While most ...
A machine learning model can use patient-reported data and remote therapeutic monitoring to accurately assess low disease ...
Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients ...
A 6-week individualized smoking cessation program led to greater quit rates among patients with RA when compared with usual care.
An observational cohort study uses multi-omics profiling to identify distinct biomarkers that could aid in the earlier ...
Rheumatoid arthritis (RA) is a chronic autoimmune disease (one in which the immune system attacks healthy cells) that primarily affects your joints. It is a progressive condition that gets worse over ...
Doctor after doctor misdiagnosed or shrugged off Ruth Wilson’s rashes, swelling, fevers and severe pain for six years. She ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback